Company: GLRE
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001385613-25-000113
Chunk: 58

Company: GREENLIGHT CAPITAL RE, LTD.
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 58
---
 transactions, including FAL, and Innovations-related private investments. 

23

Nine months ended September 30, 2025:Open MarketInnovationsCorporateTotal ConsolidatedGross premiums written$528,036 $84,455 $(541)$611,950 Net premiums written$478,092 $69,005 $(491)$546,606 Net premiums earned$434,622 $61,391 $(490)$495,523 Net loss and LAE incurred(272,828)(37,002)(1,726)(311,556)Acquisition costs(121,850)(18,939)113 (140,676)Other underwriting expenses(15,104)(5,207)— (20,311)Deposit interest expense, net(367)— — (367)Underwriting income (loss)24,473 243 (2,103)22,613 Reconciliation to income before income taxes:Net investment income (loss)17,023 (10,391)9,175 15,807 Corporate and other expenses— (1,898)(12,928)(14,826)Income from investment in Solasglas(483)(483)Foreign exchange gains (losses)8,632 8,632 Interest expense(4,038)(4,038)Income (loss) before income taxes$41,496 $(12,046)$(1,745)$27,705 Additional information:Net loss and LAE incurred:  Attritional losses$(228,187)$(35,686)$230 $(263,643)  Large event losses(12,815)— — (12,815)  CAT event losses(27,016)— — (27,016)  Prior year favorable (adverse) loss development(4,810)(1,316)(1,956)(8,082)Total net loss and LAE incurred$(272,828)$(37,002)$(1,726)$(311,556)Total allocated assets (1)$489,755 $130,382 $1,513,918 $2,134,055 (1) The Company does not allocate assets to reporting segments, with the exception of restricted cash used to collateralized certain reinsurance transactions, including FAL, and Innovations-related private investments. 

24

Nine months ended September 30, 2024: